[1] |
黄璜, 孙培元, 邹开勇, 等. 中国恶性肿瘤一级预防现状与展望[J]. 中华肿瘤杂志, 2022, 44(9): 942-949.
|
|
HUANG H, SUN P Y, ZOU K Y, et al. Current situation and prospect of primary prevention of cancer in China[J]. Chin J Oncol, 2022, 44(9): 942-949.
|
[2] |
WANGW J, ZHANGX L. Stat-quo and disease burden of cancer in China[J]. China Policy Review, 2019, (4): 63-73.
|
[3] |
QIU H B, CAO S M, XU R H. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020[J]. Cancer Commun (Lond), 2021, 41(10): 1037-1048.
|
[4] |
SØGAARD M, NØRGAARD M, DETHLEFSEN C, et al. Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study[J]. Clin Infect Dis, 2011, 52(1): 61-69.
doi: 10.1093/cid/ciq069
pmid: 21148521
|
[5] |
GUSTINETTI G, MIKULSKA M. Bloodstream infections in neutropenic cancer patients: a practical update[J]. Virulence, 2016, 7(3): 280-297.
doi: 10.1080/21505594.2016.1156821
pmid: 27002635
|
[6] |
HIONG A, THURSKY K A, VENN G, et al. Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centre[J]. Eur J Cancer Care (Engl), 2019, 28(3): e13018.
|
[7] |
陈竹凤, 林友成, 杨文韬, 等. 尿路感染相关血流感染的相关因素分析[J]. 中国卫生标准管理, 2018, 9(15): 31-33.
|
|
CHEN Z F, LINC C Y, YANG W T, et al. Analysis of related factors of urinary tract infection related bloodstream infection[J]. Chin Heal Standard Management, 2018, 9(15): 31-33.
|
[8] |
谢朝云, 熊芸, 李忠华, 等. 神经外科病人血流感染危险因素分析[J]. 中国临床神经外科杂志, 2019, 24(1): 31-34.
|
|
XIE Z Y, XIONG Y, LI Z H, et al. Analysis of risk factors of bloodstream infection in Department of Neurosurgery[J]. Chin J Clin Neurosurg, 2019, 24(1): 31-34.
|
[9] |
张力苹, 谢维宁, 林卉, 等. 恶性肿瘤合并血流感染患者的短期预后的影响因素[J]. 分子影像学杂志, 2021, 44(2): 370-377.
|
|
ZHANG L P, XIE W N, LIN H, et al. Influencing factors of short-term prognosis in patients with malignant tumor complicated with bloodstream infection[J]. J Mol Imaging, 2021, 44(2): 370-377.
|
[10] |
吴春兰. 恶性肿瘤合并血流感染的临床特点[J]. 中国医学创新, 2019, 16(27): 168-172.
|
|
WU C L. Clinical characteristics of malignant tumors complicated with bloodstream infection[J]. Med Innov China, 2019, 16(27): 168-172.
|
[11] |
中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 中华医学杂志, 2001, 81(5): 314-320.
|
|
Ministry of Health of the People's Republic of China. Diagnostic standards for hospital infection (trial)[J]. Chin J Med, 2001, 81(5): 314-320.
|
[12] |
LAMY B, SUNDQVIST M, IDELEVICH E A, et al. Blood stream infections-standard and progress in pathogen diagnostics[J]. Clin Microbiol Infect, 2020, 26(2): 142-150.
doi: 10.1016/j.cmi.2019.11.017
|
[13] |
尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 4版. 北京: 人民卫生出版社, 2015.
|
|
SHANG H, WANG Y S, SHEN Z Y. National clinical laboratory operating regulations[M]. Version 4. Beijing:People's Health Publishing House, 2015.
|
[14] |
常彦敏, 肖伟强, 孙明月, 等. 肿瘤患者血流感染病原菌分布及耐药性分析[J]. 实验与检验医学, 2022, 40(3): 268-270, 279.
|
|
CHANG Y M, XIAO W Q, SUN M Y, et al. Distribution of pathogens and analysis on resistance in bloodstream infection of patients with cancer[J]. Exp Lab Med, 2022, 40(3): 268-270, 279.
|
[15] |
AMANATI A, SAJEDIANFARD S, KHAJEH S, et al. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance[J]. BMC Infect Dis, 2021, 21(1): 636.
doi: 10.1186/s12879-021-06243-z
pmid: 34215207
|
[16] |
全国细菌耐药监测网. 全国细菌耐药监测网2014—2019年血标本病原菌耐药性变迁[J]. 中国感染控制杂志, 2021, 20(2): 124-133.
|
|
China Antimicrobial Resistance Surveillance System. Change in antimicrobial resistance of pathogens from blood specimens: surveillance report from China Antimicrobial Resistance Surveillance System in 2014-2019[J]. Chin J Infect Control, 2021, 20(2): 124-133.
|
[17] |
MASCHMEYER G, BRAVENY I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990 s[J]. Eur J Clin Microbiol Infect Dis, 2000, 19(12): 915-925.
doi: 10.1007/s100960000410
|
[18] |
CARRERAS E, VÁZQUEZ L, RODRÍGUEZ TUDELA J L, et al. Update on fungemia in oncology and hematology[J]. Enferm Infecc Microbiol Clin, 2011, 29(Suppl 4): 42-47.
|
[19] |
王一栋, 王双双, 郑永克. 铜绿假单胞菌血流感染临床特点和死亡危险因素分析[J]. 浙江临床医学, 2018, 20(7): 1244-1246.
|
|
WANG Y D, WANG S S, ZHENG Y K. Clinical characteristics and risk factors of death of Pseudomonas aeruginosa bloodstream infection[J]. Zhejiang Clin Med J, 2018, 20(7): 1244-1246.
|
[20] |
张黎, 刘正印, 徐英春, 等. 70例真菌血症的临床特点分析[J]. 中华内科杂志, 2012, 51(12): 952-956.
|
|
ZHANG L, LIU Z Y, XU Y C, et al. The clinical characteristics of 70 cases of fungemia[J]. Chin J Intern Med, 2012, 51(12): 952-956.
|
[21] |
王学满, 陈中举, 田磊, 等. 泌尿系统感染合并血流感染高危因素探讨[J]. 中国实验诊断学, 2021, 25(9): 1285-1287.
|
|
WANG X M, CHEN Z J, TIAN L, et al. Investigation of the high risk factors of urinary tract infection combined with bloodstream infection[J]. Chin J Lab Diagn, 2021, 25(9): 1285-1287.
|
[22] |
李晓东, 李欣悦, 李宝新, 等. 保定地区维持性血液透析糖尿病患者带cuff透析导管相关性血流感染的危险因素研究[J]. 临床肾脏病杂志, 2021, 21(5): 353-357.
|
|
LI X D, LI X Y, LI B X, et al. Risk factors of catheter-related bloodstream infection associated with chronic hemodialysis diabetics with cuffed dialysis catheter in Baoding area[J]. J Clin Nephrol, 2021, 21(5): 353-357.
|
[23] |
JEON C Y, FURUYA E Y, SMALDONE A, et al. Post-admission glucose levels are associated with healthcare-associated bloodstream infections and pneumonia in hospitalized patients with diabetes[J]. J Diabetes Complications, 2012, 26(6): 517-521.
doi: 10.1016/j.jdiacomp.2012.06.007
|
[24] |
PATEL T S, COTTREAU J M, HIRSCH E B, et al. Impact of hyperglycemia on outcomes of patients with Pseudomonas aeruginosa bacteremia[J]. Diagn Microbiol Infect Dis, 2016, 84(2): 155-158.
doi: 10.1016/j.diagmicrobio.2015.10.024
|
[25] |
邵素花, 万娅莉, 林莉, 等. 急性胰腺炎患者应激性高血糖与免疫功能以及临床预后的关系研究[J]. 华南国防医学杂志, 2021, 35(4): 262-265.
|
|
SHAO S H, WAN Y L, LIN L, et al. Effects of stress hyperglycemia on immune dysfunction and clinical prognosis in acute pancreatitis patients[J]. Mil Med J South China, 2021, 35(4): 262-265.
|
[26] |
邓其浪, 杨煌, 梁丹, 等. 糖尿病高血糖持续时间对大鼠体液免疫功能的影响[J]. 广东医学, 2018, 39(14): 2114-2116, 2121.
|
|
DENG Q L, YANG H, LIANG D, et al. Effects of duration of hyperglycemia on the humoral immune function in diabetic rats[J]. Guangdong Med J, 2018, 39(14): 2114-2116, 2121.
|
[27] |
CASQUEIRO J, CASQUEIRO J, ALVES C. Infections in patients with diabetes mellitus: a review of pathogenesis[J]. Indian J Endocrinol Metab, 2012, 16(Suppl1): S27-S36.
|
[28] |
ATAMNA A, AYADA G, AKIROV A, et al. High blood glucose variability is associated with bacteremia and mortality in patients hospitalized with acute infection[J]. QJM, 2019, 112(2): 101-106.
doi: 10.1093/qjmed/hcy235
pmid: 30325467
|
[29] |
PLUMMER M P, DEANE A M. Dysglycemia and glucose control during sepsis[J]. Clin Chest Med, 2016, 37(2): 309-319.
doi: 10.1016/j.ccm.2016.01.010
pmid: 27229647
|